Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy

There is limited prognostic information to identify breast cancer patients who are at risk for late recurrences after adjuvant or neoadjuvant systemic therapy (AST). We evaluated the residual risk of recurrence and prognostic factors of 2838 patients with stage I–III breast cancer who were treated w...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Natl Cancer Inst
Prif Awduron: Brewster, Abenaa M., Hortobagyi, Gabriel N., Broglio, Kristine R., Kau, Shu-Wan, Santa-Maria, Cesar A., Arun, Banu, Buzdar, Aman U., Booser, Daniel J., Valero, Vincente, Bondy, Melissa, Esteva, Francisco J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2008
Pynciau:
Brief Communications
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6592411/
https://ncbi.nlm.nih.gov/pubmed/18695137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djn233
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg